Bridion 200 MG/2 ML vial 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F7ZYW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,725
Award facts
- Contract value 100% obligated
- $29,725.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to Amerisourcebergen Drug Corp (subsidiary of Cencora, Inc.) on February 3, 2026, for the supply of Bridion 200 mg/2 mL vials. The contract carries a firm fixed price ceiling value of $29,725.25 with an ultimate completion date of February 4, 2026. This award represents a non-set-aside, competitively awarded delivery order executed under Amerisourcebergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The prime indefinite delivery vehicle, valued at $999,999,999.00 through December 2026, serves as a comprehensive pharmaceutical support mechanism enabling the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs globally.
Amerisourcebergen Drug Corp, headquartered in Conshohocken, Pennsylvania, operates as a critical vendor in the federal pharmaceutical supply chain, with extensive experience delivering brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains to Department of Defense healthcare systems. The performance location for this delivery order is the company's facility in Conshohocken, Pennsylvania. Bridion (sugammadex) is a neuromuscular blocking agent reversal agent utilized in surgical and anesthesia applications, supporting military medical treatment facility requirements. This award reflects the contractor's demonstrated capability to meet federal procurement standards through open competition and efficient fulfillment of essential medical commodities.
Quick answers
Who was awarded contract SPE2DR26F7ZYW?
SPE2DR26F7ZYW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 3, 2026.
How much is contract SPE2DR26F7ZYW worth?
The government has obligated $29,725 on SPE2DR26F7ZYW.
Is contract SPE2DR26F7ZYW an order under another contract?
Yes. SPE2DR26F7ZYW is a delivery order under SPE2DR25D7066, an indefinite delivery contract.
Was contract SPE2DR26F7ZYW competed?
The extent of competition for SPE2DR26F7ZYW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award